D. Bier

C. Reiners, D. Bier, J. Rendl, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Design, synthesis and biological evaluation of Tozadenant analogues as adenosine A2A receptor ligands.

B. Neumaier, F. Wedekind, D. Bier, 2021, European journal of medicinal chemistry.

Rapid urinary iodide test.

C. Reiners, T. Groh, D. Bier, 1998, The Journal of clinical endocrinology and metabolism.

Synthesis and evaluation of 7-amino-2-(2(3)-furyl)-5-phenylethylamino-oxazolo[5,4-d]pyrimidines as potential A2A adenosine receptor antagonists for positron emission tomography (PET).

Dirk Bier, H. Coenen, Heinz H Coenen, 2006, European journal of medicinal chemistry.

X-ray fluorescence analysis (XFA) of thyroidal iodine content (TIC) with an improved measuring system.

M. Tiemann, C. Reiners, M. Lassmann, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Relative uptake, metabolism, and beta-receptor binding of (1R,2S)-4-(18)F-fluorometaraminol and (123)I-MIBG in normotensive and spontaneously hypertensive rats.

H. Coenen, J. Ermert, D. Bier, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Effect of specific activity on cardiac uptake of iodine-123-MIBG.

C. Reiners, M. Lassmann, H. Hanscheid, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

In vivo imaging of rat brain A1 adenosine receptor occupancy by caffeine

Lutz Tellmann, Andreas Bauer, Marcus H. Holschbach, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].

C. Reiners, E. Eising, J. Farahati, 1995, Nuklearmedizin. Nuclear medicine.

Synthesis and evaluation of no-carrier-added 8-cyclopentyl-3-(3-[(18)F]fluoropropyl)-1-propylxanthine ([(18)F]CPFPX): a potent and selective A(1)-adenosine receptor antagonist for in vivo imaging.

Dirk Bier, H. Coenen, Heinz H Coenen, 2002, Journal of medicinal chemistry.

Quantification of Cerebral A1 Adenosine Receptors in Humans using [18F]CPFPX and PET

Christian Boy, Andreas Bauer, Dirk Bier, 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans.

H. Coenen, D. Bier, M. Holschbach, 2006, Drug metabolism and disposition: the biological fate of chemicals.

Metabolism of the A1 Adenosine Receptor PET Ligand [F]CPFPX in Rodents and Humans

H. Coenen, D. Bier, M. Holschbach, 2006 .

Machine Learning-aided Discovery of Novel Chemotype Antagonists for G Protein-coupled Receptors: The Case of the Adenosine A2A Receptor

P. Carloni, A. Giorgetti, B. Neumaier, 2023, bioRxiv.

First no-carrier-added radioselenation of an adenosine-A1 receptor ligand

H. Coenen, J. Ermert, D. Bier, 2004 .

Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET: an equilibrium approach

Karl Zilles, Andreas Bauer, Marcus H. Holschbach, 2005, NeuroImage.

Development and Evaluation of a Versatile Receptor-Ligand Binding Assay Using Cell Membrane Preparations Embedded in an Agarose Gel Matrix and Evaluation with the Human Adenosine A1 Receptor.

A. Baumann, B. Neumaier, D. Bier, 2020, Assay and drug development technologies.

Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor.

A. Bauer, B. Neumaier, A. Oskamp, 2019, Nuclear medicine and biology.

Rapid urinary iodide test.

C. Reiners, T. Groh, D. Bier, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Sympathomimetic effects of MIBG: comparison with tyramine.

K. Dutschka, H. Bönisch, J. Farahati, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for in vivo imaging of the A1 adenosine receptor.

D. Bier, M. Holschbach, F. Neumaier, 2024, European journal of medicinal chemistry.

Evaluation of radioiodinated 8-Cyclopentyl-3-[(E)-3-iodoprop-2-en-1-yl]-1-propylxanthine ([*I]CPIPX) as a new potential A1 adenosine receptor antagonist for SPECT.

H. Coenen, D. Bier, M. Holschbach, 2003, Nuclear medicine and biology.

Preparation and Preclinical Evaluation of 18F-Labeled Olutasidenib Derivatives for Non-Invasive Detection of Mutated Isocitrate Dehydrogenase 1 (mIDH1)

J. Ermert, C. Stegmayr, D. Bier, 2024, Molecules.